# Herbalife Ltd. share price today (Herbalife Ltd., HLF)

> Herbalife Ltd.'s balance sheet is under water: its net worth is negative, so it owes more than it owns. This is a high-risk situation: shareholders can be wiped out by new shares or a restructuring before the business recovers. HLF · Consumer Staples · Packaged Foods · data as of 4 November 2026. Page: https://www.sectoralpha.in/us/stocks/hlf

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from fewer quarters than usual
- Price: $15.31 (+68.4% in a year)
- P/E: 9.1× (higher than 97% of the last 1 year)
- Revenue (Jun 2026): $1.3 B (+5.4% on a year ago)
- Profit (Jun 2026): −$26.3 M (−153.3% on a year ago)
- Operating margin: 9.8% (−1.1 points on a year ago)
- ROE: −45%, FY25
- ROIC: 19.9%, against a 6.9% cost of capital: +13.0 points

The main question: the share price moved +68.4% in a year while yearly earnings per share moved −12.0%. The difference came from the market paying a higher multiple. ## What is the Herbalife Ltd. share price today? Herbalife Ltd.'s share price was $15.31 at the close on 4 November 2026. That is 9.6% above its average price over the last 200 trading days. In the last 52 weeks it traded between $9 and $20, and at that close it sat 57% of the way up from that low. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 4 weeks in a row. Over the last 1 year the share price moved +50% while the S&P 500 moved +23%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Herbalife Ltd. pay? Herbalife Ltd. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Herbalife Ltd. on? Herbalife Ltd. is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Herbalife Ltd. profitable? Herbalife Ltd. posted a net loss of $26.3 M in the Jun 2026 quarter. Full-year FY25 profit was $228 M. Over 4 years profit has grown −15.5% a year on average. That loss is 2.0% of the quarter's revenue. The same quarter a year earlier earned $49.3 M. 1 of the last 12 reported quarters were loss-making. Jun 2026 profit was −$26.3 M, −153.3% on a year earlier. For the full year, FY25 profit was $228 M (−10.2% on the year before). Why profit moved: revenue changed +5.4% on a year earlier and the margin moved −1.1 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed −47.9% and revenue +5.6%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Herbalife Ltd. make, and is it growing? Herbalife Ltd. reported $1.3 B of revenue in the Jun 2026 quarter, +5.4% on the same quarter a year earlier. That is the 4th quarter in a row with growth on the year before. Over 4 years it has grown −3.5% a year on average. The last full year, FY25, came in at $5.0 B. The last four reported quarters add to $5.2 B. FY25 revenue was $5.0 B, +0.9% on the year before. Recent pace: the last four quarters grew +5.6% on average, against −3.5% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +5.5%, against +1.6% a year over the last 8 quarters (accelerating); profit over the last 12 months grew −49.5%, against +41.5% a year (rolling over). ## How much of every $100 of sales does Herbalife Ltd. keep? Herbalife Ltd.'s operating margin was 9.8% in the Jun 2026 quarter, 1.1 percentage points lower than the same quarter a year ago. Across 5 years it has been between 8.1% and 12.9%. The latest quarter is within that range. Why the margin moved: operating margin changed −1.1 percentage points on the year while gross margin changed −0.3 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Herbalife Ltd.'s profit turning into cash? Over the last 3 years, 156% of Herbalife Ltd.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $333 M of operating cash against $228 M of profit. After $80.4 M of spending on assets, $253 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Herbalife Ltd.'s cash go? Herbalife Ltd. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $337 M on assets over the last 3 years. Averaged over those years that is 2.2% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $337 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Herbalife Ltd.'s P/E ratio, and how does it compare with its own history? Herbalife Ltd.'s P/E is 9.1×, near the high end of its own history: higher than 97% of past readings. Its usual P/E (the middle reading) is 6.4×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −12.0% while the price moved +68.4%. The price did better than earnings, which pushed the multiple up within its own range. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Herbalife Ltd. business getting better or worse? Herbalife Ltd.'s business is getting worse. Profit and EPS growth are shrinking: profit growth is −49.5% in the latest quarter, against +296.3% at its best in 12 quarters. This is based on 12 quarters of 3 measures, with some gaps. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. The return-on-capital line is not shown: net worth is negative, so a return on capital means nothing. The balance sheet is in distress, and this reading uses the growth lines alone. This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution. ## How much does Herbalife Ltd. earn on its capital? Herbalife Ltd. earned a ROE of −45% in FY25. Its return on capital used (ROIC) is 13.0 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 4.5% net margin and 1.81× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 4.5% net margin × 1.81× asset turnover × −5.47× leverage (assets divided by equity) ≈ −44.6% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 19.9% − 6.9% = +13.0 percentage points. The 6.9% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value. The 19.9% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 25.2%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Herbalife Ltd. have too much debt? Herbalife Ltd.'s net worth is negative: it owes more than it owns, so a debt-to-equity ratio means nothing here. Year by year, that ratio went from −2.16 in FY21 to −4.29 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the Herbalife Ltd. shareholding pattern? 9.4% of Herbalife Ltd.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 5.5 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Herbalife Ltd. from balance-sheet trouble? For Herbalife Ltd., the Z-score is 2.51. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 2.51 is in the grey area, neither clearly safe nor clearly in trouble. ## How does Herbalife Ltd. rank in its industry? 58.7 out of 100, rank 4 of 30 in Packaged Foods, with 71% of the evidence available. Herbalife Ltd. scores 58.7 out of 100 against the 30 companies it is compared with in Packaged Foods, ranking 4. Relative strength against the index is 3.1%, and revenue and profit growth are weak. The four parts add up to the total exactly: 12.1 + 18.5 + 11 + 17.1 = 58.7. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Herbalife Ltd. compared with? Herbalife Ltd. ranks 4 of 30 Packaged Foods companies on the 4-Factor Sector Score, with 58.7 out of 100. 1. [Seneca Foods Corporation](https://www.sectoralpha.in/us/stocks/seneb) SENEB · quiet · Most evidence points up · 61% evidence 68.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 31.4/43.75 · Revenue 12.5% · Profit 100% · Operating margin change -1.2 points · 83% evidence Capital efficiency 17.8/31.25 · ROCE 15.2% · Operating margin 7.2% · 76% evidence Valuation 19.6/25 · P/E 9.5× · PEG 0.26 · 65% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 31.4 + 17.8 + 19.6 = 68.8 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone. 2. [The J. M. Smucker Company](https://www.sectoralpha.in/us/stocks/sjm) SJM · breaking out · Evidence leans up · 67% evidence 62.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.1/35 · Revenue 5.1% · Profit n/a · Operating margin change 14.7 points · 71% evidence Capital efficiency 13.6/25 · ROCE 12.2% · Operating margin 17.9% · 76% evidence Valuation 8.7/20 · P/E 55.5× · PEG n/a · 15% evidence Relative strength 17.3/20 · Lead over its industry 17.2% · Lead over S&P 500 12.9% · 1 year 23.7% · 100% evidence · 8 of 12 weeks ahead Exact sum: 23.1 + 13.6 + 8.7 + 17.3 = 62.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Westrock Coffee Company](https://www.sectoralpha.in/us/stocks/west) WEST · breaking out · Evidence leans up · 64% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.1/35 · Revenue 38.5% · Profit n/a · Operating margin change 5.1 points · 62% evidence Capital efficiency 3.4/25 · ROCE -0.2% · Operating margin 0.6% · 76% evidence Valuation 11.3/20 · P/E -16.3× · PEG n/a · 15% evidence Relative strength 19.6/20 · Lead over its industry 54% · Lead over S&P 500 51% · 1 year 167.7% · 100% evidence · 6 of 12 weeks ahead Exact sum: 25.1 + 3.4 + 11.3 + 19.6 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. Herbalife Ltd. this page HLF · turning · Evidence leans up · 71% evidence 58.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.1/35 · Revenue 5.5% · Profit -49.4% · Operating margin change -1.1 points · 83% evidence Capital efficiency 18.5/25 · ROCE 26.8% · Operating margin 9.8% · 76% evidence Valuation 11.0/20 · P/E 6.3× · PEG n/a · 15% evidence Relative strength 17.1/20 · Lead over its industry 8.1% · Lead over S&P 500 3.1% · 1 year 68.4% · 100% evidence · 3 of 12 weeks ahead Exact sum: 12.1 + 18.5 + 11 + 17.1 = 58.7 · What this means: Relative strength against the index is 3.1%, and revenue and profit growth are weak. 5. [Central Garden & Pet Company](https://www.sectoralpha.in/us/stocks/cent) CENT · turning · Evidence leans up · 81% evidence 57.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.1/35 · Revenue -1.2% · Profit 19.4% · Operating margin change -0.2 points · 83% evidence Capital efficiency 9.9/25 · ROCE 8.2% · Operating margin 14.3% · 76% evidence Valuation 13.1/20 · P/E 15.2× · PEG 0.68 · 65% evidence Relative strength 16.6/20 · Lead over its industry 21.3% · Lead over S&P 500 17.1% · 1 year 54% · 100% evidence · 3 of 12 weeks ahead Exact sum: 18.1 + 9.9 + 13.1 + 16.6 = 57.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. McCormick & Company, Incorporated MKC-V · basing · Evidence leans up · 85% evidence 54.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.3/35 · Revenue 13.2% · Profit 91.7% · Operating margin change 0.7 points · 95% evidence Capital efficiency 15.2/25 · ROCE 10.5% · Operating margin 17.8% · 76% evidence Valuation 6.8/20 · P/E 9.8× · PEG 2.64 · 65% evidence Relative strength 6.3/20 · Lead over its industry -11.1% · Lead over S&P 500 -15.5% · 1 year -21.6% · 100% evidence · 3 of 12 weeks ahead Exact sum: 26.3 + 15.2 + 6.8 + 6.3 = 54.6 · What this means: Earnings are strong; relative strength in its sector is -11.1% and the one-year return is -21.6%. 7. [Nomad Foods Limited](https://www.sectoralpha.in/us/stocks/nomd) NOMD · turning · Evidence leans up · 81% evidence 51.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.7/35 · Revenue -3.5% · Profit -40.8% · Operating margin change 0.1 points · 83% evidence Capital efficiency 10.4/25 · ROCE 7.3% · Operating margin 13.9% · 76% evidence Valuation 10.5/20 · P/E 10.8× · PEG 1.45 · 65% evidence Relative strength 16.4/20 · Lead over its industry 9% · Lead over S&P 500 4.3% · 1 year 3.4% · 100% evidence · 4 of 12 weeks ahead Exact sum: 13.7 + 10.4 + 10.5 + 16.4 = 51 · What this means: Relative strength against the index is 4.3%, and revenue and profit growth are weak. 8. [BellRing Brands, Inc.](https://www.sectoralpha.in/us/stocks/brbr) BRBR · basing · Evidence leans up · 81% evidence 50.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.3/35 · Revenue 5.8% · Profit -24.9% · Operating margin change -9.1 points · 83% evidence Capital efficiency 20.1/25 · ROCE 54% · Operating margin 11.5% · 76% evidence Valuation 14.1/20 · P/E 8.8× · PEG 0.69 · 65% evidence Relative strength 5.3/20 · Lead over its industry -37.2% · Lead over S&P 500 -41.5% · 1 year -65.1% · 100% evidence · 3 of 12 weeks ahead Exact sum: 11.3 + 20.1 + 14.1 + 5.3 = 50.8 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 9. [Smithfield Foods, Inc.](https://www.sectoralpha.in/us/stocks/sfd) SFD · basing · Evidence leans up · 81% evidence 50.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.4/35 · Revenue 4.3% · Profit 15.8% · Operating margin change 0.4 points · 83% evidence Capital efficiency 13.4/25 · ROCE 13.5% · Operating margin 8.4% · 76% evidence Valuation 14.5/20 · P/E 9.3× · PEG 0.67 · 65% evidence Relative strength 1.3/20 · Lead over its industry -18.6% · Lead over S&P 500 -22% · 1 year -9.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 21.4 + 13.4 + 14.5 + 1.3 = 50.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [The Marzetti Company](https://www.sectoralpha.in/us/stocks/mzti) MZTI · basing · Evidence leans up · 81% evidence 50.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.0/35 · Revenue 1.1% · Profit 14.4% · Operating margin change 1.5 points · 83% evidence Capital efficiency 16.8/25 · ROCE 17.3% · Operating margin 10.9% · 76% evidence Valuation 10.9/20 · P/E 16.4× · PEG 1.1 · 65% evidence Relative strength 5.9/20 · Lead over its industry -16.9% · Lead over S&P 500 -21.4% · 1 year -35% · 100% evidence · 0 of 12 weeks ahead Exact sum: 17 + 16.8 + 10.9 + 5.9 = 50.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Freshpet, Inc.](https://www.sectoralpha.in/us/stocks/frpt) FRPT · breaking out · Evidence leans up · 81% evidence 50.0 out of 100 Growth Capital Valuation Relative
12. [Lamb Weston Holdings, Inc.](https://www.sectoralpha.in/us/stocks/lw) LW · turning · Evidence leans down · 85% evidence 49.7 out of 100 Growth Capital Valuation Relative
13. [Darling Ingredients Inc.](https://www.sectoralpha.in/us/stocks/dar) DAR · quiet · Too little evidence to rank firmly · 58% evidence 47.2 out of 100 Growth Capital Valuation Relative
14. [John B. Sanfilippo & Son, Inc.](https://www.sectoralpha.in/us/stocks/jbss) JBSS · quiet · Evidence leans down · 81% evidence 46.5 out of 100 Growth Capital Valuation Relative
15. [Ingredion Incorporated](https://www.sectoralpha.in/us/stocks/ingr) INGR · basing · Evidence leans down · 81% evidence 46.1 out of 100 Growth Capital Valuation Relative
16. [General Mills, Inc.](https://www.sectoralpha.in/us/stocks/gis) GIS · basing · Evidence leans down · 75% evidence 46.1 out of 100 Growth Capital Valuation Relative
17. [The Kraft Heinz Company](https://www.sectoralpha.in/us/stocks/khc) KHC · turning · Evidence leans down · 64% evidence 45.5 out of 100 Growth Capital Valuation Relative
18. [The Campbell's Company](https://www.sectoralpha.in/us/stocks/cpb) CPB · turning · Evidence leans down · 85% evidence 44.2 out of 100 Growth Capital Valuation Relative
19. [Hormel Foods Corporation](https://www.sectoralpha.in/us/stocks/hrl) HRL · basing · Evidence leans down · 75% evidence 42.8 out of 100 Growth Capital Valuation Relative
20. [Pilgrim's Pride Corporation](https://www.sectoralpha.in/us/stocks/ppc) PPC · turning · Evidence leans down · 81% evidence 42.1 out of 100 Growth Capital Valuation Relative
21. [J&J Snack Foods Corp.](https://www.sectoralpha.in/us/stocks/jjsf) JJSF · quiet · Evidence leans down · 81% evidence 41.8 out of 100 Growth Capital Valuation Relative
22. [Post Holdings, Inc.](https://www.sectoralpha.in/us/stocks/post) POST · turning · Evidence leans down · 81% evidence 41.4 out of 100 Growth Capital Valuation Relative
23. [JBS N.V.](https://www.sectoralpha.in/us/stocks/jbs) JBS · quiet · Evidence leans down · 81% evidence 41.3 out of 100 Growth Capital Valuation Relative
24. [Conagra Brands, Inc.](https://www.sectoralpha.in/us/stocks/cag) CAG · turning · Evidence leans down · 75% evidence 40.8 out of 100 Growth Capital Valuation Relative
25. [Flowers Foods, Inc.](https://www.sectoralpha.in/us/stocks/flo) FLO · basing · Too little evidence to rank firmly · 58% evidence 40.2 out of 100 Growth Capital Valuation Relative
26. [The Simply Good Foods Company](https://www.sectoralpha.in/us/stocks/smpl) SMPL · turning · Evidence leans down · 71% evidence 39.8 out of 100 Growth Capital Valuation Relative
27. [Mama's Creations, Inc.](https://www.sectoralpha.in/us/stocks/mama) MAMA · quiet · Evidence leans down · 85% evidence 36.3 out of 100 Growth Capital Valuation Relative
28. [Utz Brands, Inc.](https://www.sectoralpha.in/us/stocks/utz) UTZ · losing its lead · Evidence leans down · 71% evidence 36.1 out of 100 Growth Capital Valuation Relative
29. [The Magnum Ice Cream Company N.V.](https://www.sectoralpha.in/us/stocks/micc) MICC · turning · Too little evidence to rank firmly · 31% evidence 51.5 out of 100 Growth Capital Valuation Relative
30. [Once Upon A Farm, PBC](https://www.sectoralpha.in/us/stocks/ofrm) OFRM · quiet · Too little evidence to rank firmly · 41% evidence 41.5 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Packaged Foods](https://www.sectoralpha.in/us/sectors/packaged-foods), all 30 compared on one page. ## Which companies are close to Herbalife Ltd. in size? Herbalife Ltd. is the 22nd largest of 39 Packaged Foods companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Utz Brands, Inc., Nomad Foods and J&J Snack Foods Corp. Just below it: Flowers Foods, Inc., BellRing Brands, Inc. and The Simply Good Foods Company. ### Packaged Foods companies close in size

1. [Utz Brands, Inc.](https://www.sectoralpha.in/us/stocks/utz) $2.1 billion
2. [Nomad Foods Limited](https://www.sectoralpha.in/us/stocks/nomd) $1.8 billion
3. [J&J Snack Foods Corp.](https://www.sectoralpha.in/us/stocks/jjsf) $1.7 billion
4. Herbalife Ltd. $1.6 billion
5. [Flowers Foods, Inc.](https://www.sectoralpha.in/us/stocks/flo) $1.5 billion
6. [BellRing Brands, Inc.](https://www.sectoralpha.in/us/stocks/brbr) $1.2 billion
7. [The Simply Good Foods Company](https://www.sectoralpha.in/us/stocks/smpl) $1.2 billion

[All 39 Packaged Foods companies, largest first](https://www.sectoralpha.in/us/sectors/packaged-foods#all-companies)

### Companies close in size in other industries

1. [Century Communities, Inc.](https://www.sectoralpha.in/us/stocks/ccs) $1.6 billion · Real Estate - Development
2. [Stepan Company](https://www.sectoralpha.in/us/stocks/scl) $1.6 billion · Specialty Chemicals
3. Herbalife Ltd. $1.6 billion
4. [Phibro Animal Health Corporation](https://www.sectoralpha.in/us/stocks/pahc) $1.6 billion · Drug Manufacturers - Specialty & Generic
5. [CONMED Corporation](https://www.sectoralpha.in/us/stocks/cnmd) $1.6 billion · Medical Devices

## What else do people ask about Herbalife Ltd.? ### What were Herbalife Ltd. Ltd.'s latest quarterly results? Herbalife Ltd. reported revenue of $1.3 B and a net loss of $26.3 M for the Jun 2026 quarter. Revenue rose 5.4% and profit fell 153.3% compared with a year earlier. Earnings per share were −$0.25. The operating margin was 9.8%, 1.1 percentage points lower than a year earlier (as of 4 November 2026). ### What is Herbalife Ltd. Ltd.'s market cap? Herbalife Ltd.'s market capitalisation is $1.6 B at a stock price of $15.31. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Herbalife Ltd. Ltd. performing? Herbalife Ltd.'s latest readings are below. In its latest quarter, revenue rose 5.4% and profit fell 153.3% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 4 weeks running. This describes what the data did, not a rating (as of 4 November 2026). ### Will Herbalife Ltd. Ltd.'s stock price go up? This page does not forecast Herbalife Ltd.'s stock price. What it shows instead: the stock price is $15.31. Its P/E of 9.1× is higher than 97% of its own last 1 years. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026). ### Where is Herbalife Ltd. Ltd. in its business cycle? Herbalife Ltd.'s FY25 operating margin was 9.9%, against a 5-year range of 8.1% to 12.9%: the middle of its own range, neither a peak nor a low. The latest quarter was 9.8%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Herbalife Ltd. Ltd. story? The main question: the share price moved +68.4% in a year while yearly earnings per share moved −12.0%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Herbalife Ltd. Ltd. a stock worth studying right now? What the numbers show: Herbalife Ltd.'s balance sheet is under water: its net worth is negative, so it owes more than it owns. This is a high-risk situation: shareholders can be wiped out by new shares or a restructuring before the business recovers. The main open question: whether the business can earn its way back to positive net worth before new shares or a restructuring get there first. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). This is research, not advice. We’re not SEBI-registered.